Healthcare providers’ utilization and perception on telemedicine: urgency amidst COVID-19 pandemic

Silvalena Silvalena, Rizma Adlia Syakurah

Abstract


The outbreak of coronavirus disease 2019 (COVID-19) in Indonesia had awakened the fact that the country’s healthcare system could not stand-alone with conventional in-person healthcare service. The sudden massive adaptation of telemedicine in Indonesia still needed be reassess periodically, especially with blooming numbers of users. This cross-sectional study conducted on medical doctors, dentists, and specialist in Indonesia, aimed to evaluate the utilization and perception of healthcare providers towards telemedicine in Indonesia during COVID-19 pandemic. Data were collected using convenience sampling from an online questionnaire through social media from June 16-29, 2020. Data were analyzed using Chi-square test (p-value<0.05) and prevalence ratios (PR) with 95% confidence interval (CI). Most physicians who practiced using telemedicine admitted that they used telemedicine as an alternative during pandemic (71.2%). The usage of telemedicine had an association with the idea that telemedicine provided the patients’ needs (p<0.001, 95% CI=3.53 (1.86-6.70) and provided knowledge for the society (p=.047 95% CI=3.54 (0.93-13.51)). The potential and benefits of telemedicine could be recognized during the pandemic, though the use of collaborative media and the advancement of platform features for a better quality of diagnosis could be improved The policymakers and stakeholders expected to establish a balanced and thoughtful framework of telemedicine.

Full Text:

PDF


DOI: http://doi.org/10.11591/ijphs.v11i1.20978

Refbacks

  • There are currently no refbacks.


International Journal of Public Health Science (IJPHS)
p-ISSN: 2252-8806, e-ISSN: 2620-4126

This journal is published by the Intelektual Pustaka Media Utama (IPMU) in collaboration with Institute of Advanced Engineering and Science (IAES).

View IJPHS Stats

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.